Trade Medtronic - MDT CFD

Add to favourite

79.42

0.37%

0.15

Low: 79.12

High: 79.54

Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

Summary
Historical Data
Events
Income Statement
Balance Sheet
Cash Flow

Trading сonditions

Spread

0.15

Long position overnight fee

-0.026179%

Short position overnight fee

0.003957%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

Stock exchange

United States of America

Commission on trade

*Information provided by Capital.com

Medtronic PLC ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats

Prev. Close*	79.13
Open*	79.45
1-Year Change*	-2.77%
Day's Range*	79.12 - 79.54
52 wk Range	68.84-92.02
Average Volume (10 days)	6.14M
Average Volume (3 months)	134.64M
Market Cap	114.74B
P/E Ratio	28.03
Shares Outstanding	1.33B
Revenue	31.96B
EPS	3.08
Dividend (Yield %)	3.19852
Beta	0.79
Next Earnings Date	Feb 20, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 19, 2024	79.42	0.02	0.03%	79.40	79.57	78.89
Apr 18, 2024	79.13	0.10	0.13%	79.03	79.24	78.36
Apr 17, 2024	78.98	-0.19	-0.24%	79.17	79.77	78.88
Apr 16, 2024	79.16	-1.02	-1.27%	80.18	80.25	78.71
Apr 15, 2024	80.18	-0.66	-0.82%	80.84	81.45	79.80
Apr 12, 2024	80.06	-1.39	-1.71%	81.45	81.65	79.51
Apr 11, 2024	82.10	-0.61	-0.74%	82.71	82.95	82.06
Apr 10, 2024	82.23	-0.39	-0.47%	82.62	83.23	81.77
Apr 9, 2024	83.72	0.47	0.56%	83.25	83.77	82.69
Apr 8, 2024	82.86	-1.28	-1.52%	84.14	84.15	82.31
Apr 5, 2024	84.48	1.22	1.47%	83.26	84.62	82.95
Apr 4, 2024	83.85	-1.09	-1.28%	84.94	85.34	83.68
Apr 3, 2024	84.95	-0.07	-0.08%	85.02	85.61	84.67
Apr 2, 2024	85.12	-1.38	-1.60%	86.50	86.75	84.88
Apr 1, 2024	86.95	0.31	0.36%	86.64	87.09	86.36
Mar 28, 2024	87.06	-0.02	-0.02%	87.08	87.63	86.84
Mar 27, 2024	86.88	3.43	4.11%	83.45	86.97	83.45
Mar 26, 2024	83.66	0.30	0.36%	83.36	83.81	82.98
Mar 25, 2024	83.16	0.70	0.85%	82.46	83.34	82.46
Mar 22, 2024	83.01	-0.50	-0.60%	83.51	83.80	82.88

Medtronic Events

Time (UTC)	Country	Event
Thursday, May 23, 2024
Time (UTC) 12:00	Country IE	Event Q4 2024 Medtronic PLC Earnings Call Q4 2024 Medtronic PLC Earnings Call Forecast - Previous -
Time (UTC) 12:30	Country IE	Event Q4 2024 Medtronic PLC Earnings Release Q4 2024 Medtronic PLC Earnings Release Forecast - Previous -
Tuesday, August 20, 2024
Time (UTC) 12:00	Country IE	Event Q1 2025 Medtronic PLC Earnings Call Q1 2025 Medtronic PLC Earnings Call Forecast - Previous -
Time (UTC) 12:30	Country IE	Event Q1 2025 Medtronic PLC Earnings Release Q1 2025 Medtronic PLC Earnings Release Forecast - Previous -

View all events

Annual
Quarterly

	2023	2022	2021	2020	2019
Total revenue	31227	31686	30117	28913	30557
Revenue	31227	31686	30117	28913	30557
Cost of Revenue, Total	10622	9971	10355	9269	9064
Gross Profit	20605	21715	19762	19644	21493
Total Operating Expense	25795	25934	25941	24535	24774
Selling/General/Admin. Expenses, Total	10242	10135	9776	9875	10232
Research & Development	2696	2746	2493	2331	2330
Depreciation / Amortization	1698	1733	1783	1756	1764
Interest Expense (Income) - Net Operating				-117	-224
Unusual Expense (Income)	914	1154	1219	1303	1342
Other Operating Expenses, Total	-377	195	315	118	266
Operating Income	5432	5752	4176	4378	5783
Interest Income (Expense), Net Non-Operating	-164	-541	-425	-379	-676
Other, Net	96	306	144	56	90
Net Income Before Taxes	5364	5517	3895	4055	5197
Net Income After Taxes	3784	5061	3524	4743	4662
Minority Interest	-26	-22	-24	-17	-19
Net Income Before Extra. Items	3758	5039	3500	4726	4643
Net Income	3758	5039	3606	4789	4631
Income Available to Common Excl. Extra. Items	3758	5039	3500	4726	4643
Income Available to Common Incl. Extra. Items	3758	5039	3606	4789	4631
Diluted Net Income	3758	5039	3606	4789	4631
Diluted Weighted Average Shares	1332.8	1351.4	1354	1351.1	1357.5
Diluted EPS Excluding Extraordinary Items	2.81963	3.72873	2.58493	3.49789	3.42026
Dividends per Share - Common Stock Primary Issue	2.72	2.52	2.32	2.16	2
Diluted Normalized EPS	2.93517	4.58931	3.55835	4.13123	4.31147
Total Extraordinary Items			106	63	-12
Total Adjustments to Net Income		0

	Jul 2023	Apr 2023	Jan 2023	Oct 2022	Jul 2022
Total revenue	7702	8545	7727	7585	7371
Revenue	7702	8545	7727	7585	7371
Cost of Revenue, Total	2612	2949	2663	2516	2497
Gross Profit	5090	5596	5064	5069	4874
Total Operating Expense	6434	6980	6335	6185	6306
Selling/General/Admin. Expenses, Total	2592	2568	2575	2572	2526
Research & Development	668	641	688	676	692
Depreciation / Amortization	429	423	431	421	423
Unusual Expense (Income)	131	446	128	114	236
Other Operating Expenses, Total	2	-47	-150	-114	-68
Operating Income	1268	1565	1392	1400	1065
Interest Income (Expense), Net Non-Operating	-101	-36	-41	-33	-24
Other, Net	29	22	24	28	3
Net Income Before Taxes	1196	1551	1375	1395	1044
Net Income After Taxes	796	1189	1229	436	932
Minority Interest	-6	-9	-6	-8	-2
Net Income Before Extra. Items	790	1180	1223	428	930
Net Income	790	1180	1223	428	930
Income Available to Common Excl. Extra. Items	791	1179	1222	427	929
Income Available to Common Incl. Extra. Items	791	1179	1222	427	929
Diluted Net Income	791	1179	1222	427	929
Diluted Weighted Average Shares	1330.5	1332.8	1332	1332	1329.4
Diluted EPS Excluding Extraordinary Items	0.59451	0.8846	0.91742	0.32057	0.69881
Dividends per Share - Common Stock Primary Issue	0.69	0.68	0.68	0.68	0.68
Diluted Normalized EPS	0.7283	1.15621	1.03904	-0.16141	0.86054
Total Adjustments to Net Income	1	-1	-1	-1	-1

Annual
Quarterly

	2023	2022	2021	2020	2019
Total Current Assets	21675	23059	22548	22031	21967
Cash and Short Term Investments	7959	10573	10817	10948	9848
Cash & Equivalents	1543	3714	3593	4140	4393
Short Term Investments	6416	6859	7224	6808	5455
Total Receivables, Net	5998	5551	5462	4645	6222
Accounts Receivable - Trade, Net	5998	5551	5462	4645	6222
Total Inventory	5293	4616	4313	4229	3753
Other Current Assets, Total	2425	2319	1956	2209	2144
Total Assets	90948	90981	93083	90689	89694
Property/Plant/Equipment, Total - Net	6610	6267	6219	5755	4675
Property/Plant/Equipment, Total - Gross	15103	14219	13698	12571	10920
Accumulated Depreciation, Total	-8493	-7952	-7479	-6816	-6245
Goodwill, Net	41425	40502	41961	39841	39959
Intangibles, Net	14844	15595	17740	19063	20560
Long Term Investments	1607	881	687	480	372
Other Long Term Assets, Total	4787	4677	3928	3519	2161
Total Current Liabilities	9051	12394	8509	10366	8472
Accounts Payable	2662	2276	2106	1996	1953
Accrued Expenses	5216	5367	5681	4839	4885
Notes Payable/Short Term Debt	0	0	0	0	0
Current Port. of LT Debt/Capital Leases	20	3742	11	2776	838
Other Current Liabilities, Total	1153	1009	711	755	796
Total Liabilities	39465	38430	41655	39952	39603
Total Long Term Debt	24344	20372	26378	22021	24486
Long Term Debt	24287	20316	26316	21976	24476
Capital Lease Obligations	57	56	62	45	10
Deferred Income Tax	708	884	1028	1174	1278
Minority Interest	182	171	174	135	121
Other Liabilities, Total	5180	4609	5566	6256	5246
Total Equity	51483	52551	51428	50737	50091
Common Stock	0.1331	0.13307	0.13454	0.13411	0.13407
Additional Paid-In Capital	24590	24566	26319	26165	26532
Retained Earnings (Accumulated Deficit)	30392	30250	28594	28132	26270
Unrealized Gain (Loss)	-258	-209	92	0	-45
Other Equity, Total	-3241.13	-2056.13	-3577.13	-3560.13	-2666.13
Total Liabilities & Shareholders’ Equity	90948	90981	93083	90689	89694
Total Common Shares Outstanding	1330.81	1330.74	1345.4	1341.07	1340.7

	Jul 2023	Apr 2023	Jan 2023	Oct 2022	Jul 2022
Total Current Assets	21869	21675	25364	25398	22135
Cash and Short Term Investments	7876	7959	11137	11430	8873
Cash & Equivalents	1339	1543	4521	4828	2140
Short Term Investments	6537	6416	6616	6602	6733
Total Receivables, Net	5806	5998	5887	5626	5308
Accounts Receivable - Trade, Net	5806	5998	5887	5626	5308
Total Inventory	5668	5293	5375	5055	4809
Other Current Assets, Total	2519	2425	2965	3287	3145
Total Assets	90776	90948	94134	93241	89914
Property/Plant/Equipment, Total - Net	5665	5569	5437	5298	5281
Property/Plant/Equipment, Total - Gross		14062	13926	13497	13323
Accumulated Depreciation, Total		-8493	-8489	-8199	-8043
Goodwill, Net	41436	41425	41565	40417	40324
Intangibles, Net	14434	14844	15265	15655	15775
Long Term Investments	1569	1076	980	912	880
Other Long Term Assets, Total	5803	6359	5523	5561	5519
Total Current Liabilities	9047	9051	14422	14465	14049
Accounts Payable	2239	2662	2209	2198	2180
Accrued Expenses	4942	5530	5637	5752	5589
Notes Payable/Short Term Debt	500	0	0	0	0
Current Port. of LT Debt/Capital Leases	19	20	5918	5864	5729
Other Current Liabilities, Total	1347	839	658	651	551
Total Liabilities	39598	39465	42693	41361	37241
Total Long Term Debt	24463	24344	22210	20753	17481
Long Term Debt	24406	24287	22155	20698	17423
Capital Lease Obligations	57	57	55	55	58
Deferred Income Tax	687	708	747	871	899
Minority Interest	188	182	177	177	170
Other Liabilities, Total	5213	5180	5137	5095	4642
Total Equity	51178	51483	51441	51880	52673
Common Stock	0.13304	0.1331	0.13303	0.1331	0.1329
Additional Paid-In Capital	24587	24590	24513	24442	24335
Retained Earnings (Accumulated Deficit)	30265	30392	30117	29799	30276
Unrealized Gain (Loss)	-277	-258	-285	-392	-225
Other Equity, Total	-3397.13	-3241.13	-2904.13	-1969.13	-1713.13
Total Liabilities & Shareholders’ Equity	90776	90948	94134	93241	89914
Total Common Shares Outstanding	1330.5	1330.81	1330.38	1330.15	1329.28

Annual
Quarterly

	2023	2022	2021	2020	2019
Net income/Starting Line	3784	5062	3630	4806	4650
Cash From Operating Activities	6039	7347	6240	7234	7007
Cash From Operating Activities	2697	2707	2702	2663	2659
Deferred Taxes	-226	-604	-422	-1315	-304
Non-Cash Items	751	1070	1031	1019	1082
Cash Taxes Paid	1548	996	1250	878	1558
Cash Interest Paid	606	540	582	643	973
Changes in Working Capital	-967	-888	-701	61	-1080
Cash From Investing Activities	-3493	-1659	-2866	-3203	-774
Capital Expenditures	-1459	-1368	-1355	-1213	-1134
Other Investing Cash Flow Items, Total	-2034	-291	-1511	-1990	360
Cash From Financing Activities	-4960	-5336	-4136	-4198	-5431
Financing Cash Flow Items	-409	163	-268	-81	14
Total Cash Dividends Paid	-3616	-3383	-3120	-2894	-2693
Issuance (Retirement) of Stock, Net	-337	-2115	-178	-664	-1885
Issuance (Retirement) of Debt, Net	-598	-1	-570	-559	-867
Foreign Exchange Effects	243	-231	215	-86	-78
Net Change in Cash	-2171	121	-547	-253	724

	Apr 2023	Jan 2023	Oct 2022	Jul 2022	Apr 2022
Net income/Starting Line	3784	2595	1367	931	5062
Cash From Operating Activities	6039	3579	2004	1083	7347
Cash From Operating Activities	2697	2018	1339	668	2707
Deferred Taxes	-226	-78	-92	-18	-604
Non-Cash Items	751	569	441	251	1070
Cash Taxes Paid	1548	1314	821	260	996
Cash Interest Paid	606	262	234	68	540
Changes in Working Capital	-967	-1525	-1051	-749	-888
Cash From Investing Activities	-3493	-3018	-2731	-1585	-1659
Capital Expenditures	-1459	-1081	-749	-426	-1368
Other Investing Cash Flow Items, Total	-2034	-1937	-1982	-1159	-291
Cash From Financing Activities	-4960	-70	2064	-950	-5336
Financing Cash Flow Items	-409	-276	443	273	163
Total Cash Dividends Paid	-3616	-2711	-1807	-903	-3383
Issuance (Retirement) of Stock, Net	-337	-339	-324	-293	-2115
Issuance (Retirement) of Debt, Net	-598	3256	3752	-27	-1
Foreign Exchange Effects	243	317	-223	-122	-231
Net Change in Cash	-2171	808	1114	-1574	121

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Medtronic Company profile

Medtronic (MDT) is a global medical device manufacturer, headquartered in Dublin. Established in 1949, Medtronic managed to grow into the world’s biggest provider of medical services and solutions through a number of acquisitions. The company has six principal departments that create devices and equipment for the treatment of chronic diseases. The company’s main business units focus on diabetes, cardiac diseases management, and surgical technologies. Medtronic trades on the New York Stock Exchange (NYSE) and is featured in the S&P100 Index. Download the Capital.com app to get regular updates on the Medtronic share price data.

Industry:

Medical Equipment, Supplies & Distribution (NEC)

20 On Hatch
Hatch Street Lower
DUBLIN
DUBLIN
IE

Income Statement

Annual
Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024